NASDAQ:CPRX - Nasdaq - US14888U1016 - Common Stock - Currency: USD
CPRX gets a fundamental rating of 8 out of 10. The analysis compared the fundamentals against 558 industry peers in the Biotechnology industry. CPRX scores excellent points on both the profitability and health parts. This is a solid base for a good stock. CPRX is evaluated to be cheap and growing strongly. This does not happen too often! These ratings would make CPRX suitable for value and growth and quality investing!
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 21.71% | ||
ROE | 24.85% | ||
ROIC | 21.96% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 43.27% | ||
PM (TTM) | 36.91% | ||
GM | 86.11% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | 0 | ||
Altman-Z | 16.41 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 6.14 | ||
Quick Ratio | 5.96 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 13.39 | ||
Fwd PE | 12.19 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 9.59 | ||
EV/EBITDA | 7.56 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
21.03
-0.42 (-1.96%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 13.39 | ||
Fwd PE | 12.19 | ||
P/S | 4.8 | ||
P/FCF | 9.59 | ||
P/OCF | 9.57 | ||
P/B | 3.23 | ||
P/tB | 3.97 | ||
EV/EBITDA | 7.56 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 21.71% | ||
ROE | 24.85% | ||
ROCE | 29.02% | ||
ROIC | 21.96% | ||
ROICexc | 80.84% | ||
ROICexgc | 252.85% | ||
OM | 43.27% | ||
PM (TTM) | 36.91% | ||
GM | 86.11% | ||
FCFM | 50.05% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | 0 | ||
Debt/EBITDA | 0 | ||
Cap/Depr | 0.94% | ||
Cap/Sales | 0.07% | ||
Interest Coverage | 161.46 | ||
Cash Conversion | 99.54% | ||
Profit Quality | 135.58% | ||
Current Ratio | 6.14 | ||
Quick Ratio | 5.96 | ||
Altman-Z | 16.41 |